Hypericum perforatum CO2 Extract and Opioid Receptor Antagonists Act Synergistically to Reduce Ethanol Intake in Alcohol-Preferring Rats

Alcoholism: Clinical and Experimental Research

Volumn 27, Issue 10, 2003, Pages 1554-1562

  Perfumi, Marina ^a   Santoni, Manuela ^a   Cippitelli, Andrea ^a   Ciccocioppo, Roberto ^a   Froldi, Rino ^b   Massi, Maurizio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF MACERATA   (Italy)

Author keywords

Alcohol Intake; Alcohol Preferring Rats; Hypericum perforatum; Opioid Receptor Antagonists; St. John's Wort

Indexed keywords

ALCOHOL; HYPERICUM PERFORATUM EXTRACT; NALOXONE; NALTREXONE; OPIATE ANTAGONIST; CARBON DIOXIDE; NARCOTIC ANTAGONIST; OPIATE RECEPTOR; PLANT EXTRACT;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; FLUID INTAKE; FOOD INTAKE; GENETIC SELECTION; HYPERICUM PERFORATUM; LIGHT DARK CYCLE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; TAIL FLICK TEST; ANIMAL; BLOOD; COMPARATIVE STUDY; DRINKING BEHAVIOR; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HYPERICUM; ISOLATION AND PURIFICATION; MOTOR ACTIVITY; PHYSIOLOGY;

ANIMALIA; HYPERICUM; HYPERICUM PERFORATUM;

ALCOHOL DRINKING; ANIMALS; CARBON DIOXIDE; DRUG SYNERGISM; ETHANOL; HYPERICUM; MALE; MOTOR ACTIVITY; NARCOTIC ANTAGONISTS; PLANT EXTRACTS; RATS; RECEPTORS, OPIOID;

EID: 0041302904     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000092062.60924.56     Document Type: Article

References (62)

1. Barnes J, Anderson LA, Phillipson JD (2001) St. John's Wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 53:583-600.
2. Bienkowski P, Kostowski W, Koros E (1999) Ethanol-reinforced behaviour in the rat: effects of naltrexone. Eur J Pharmacol 374:321-327.
3. Brown DR, Holtzman SG (1979) Suppression of deprivation-induced food and water intake in rats and mice by naloxone. Pharmacol Biochem Behav 11:567-573.
4. Butterweck V, Wall A, Lieflander-Wulf U, Winterhoff H, Nahrstedt A (1997) Effects of total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry (Suppl) 30:117-124.
5. Chatterjee SS, Bhattacharya SK, Wonnemann M, Singer A, Muller WE (1998) Hyperforin as a possible antidepressant component of Hypericum extracts. Life Sci 63:499-510.
6. Cingolani M, Ferrante L, Froldi R (1991) Valutazione della validita' di un micrometodo per analisi alcoolimetrica in head space. Riv Ital Med Leg 13:163-170.
7. Colombo G (1997) Ethanol drinking behaviour in Sardinian alcohol-preferring rats. Alcohol Alcohol 32:443-453.
8. Cooper SJ (1983) Effects of opiate agonists and antagonists on fluid intake and saccharin choice in the rat. Neuropharmacology 22:323-328.
9. Davidson D, Amit Z (1997) Naltrexone blocks acquisition of voluntary ethanol intake in rats. Alcohol Clin Exp Res 21:677-683.
10. Davidson D, Palfai T, Bird C, Swift R (1999) Effects of naltrexone on alcohol self-administration in heavy drinkers. Alcohol Clin Exp Res 23:195-203.
11. De Vry J, Maurel S, Schreiber R, de Beun R, Jentzsch KR (1999) Comparison of hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism. Eur J Neuropsychopharmacol 10:37-42.
12. Farren CK, Catapano D, O'Malley S (1997) Sertraline with naltrexone versus naltrexone alone in the treatment of alcohol dependence. Alcohol Clin Exp Res (Suppl) 21:64.
13. Flausino OA Jr, Zangrossi H Jr, Salgado JV, Viana MB (2002) Effect of acute and chronic treatment with Hypericum perforatum L. (LI160) on different anxiety-related responses in rats. Pharmacol Biochem Behav 71:251-257.
14. Froehlich JC, Harts J, Lumeng L, Li T-K (1990) Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav 35:385-390.
15. Gambarana C, Ghiglieri O, Tolu P, De Montis MG, Giachetti D, Bombardelli E, Tagliamonte A (1999) Efficacy of an Hypericum perforatum (St. John's wort) extract in preventing and reverting a condition of escape deficit in rats. Neuropsychopharmacology 21:247-257.
16. Gambarana C, Tolu PL, Masi F, Rinaldi M, Giachetti D, Morazzoni P, De Montis MG (2001) A study of the antidepressant activity of Hypericum perforatum on animal models. Pharmacopsychiatry (Suppl 1) 34:S42-S44.
17. Gardmark M, Hoglund AU, Hammarlund-Udenaes M (1998) Aspect on tail-flick, hot-plate and electrical stimulation tests for morphine antinociception. Pharmacol Toxicol 83:252-258.
18. Gessa GL, Colombo G, Fadda F (1991) Rat lines genetically selected for difference in voluntary ethanol consumption, in Current Practices and Future Developments in the Pharmacotherapy of Mental Disorders (Meltzer HY, Nerozzi D eds), pp 193-200. Excerpta Medica, Amsterdam.
19. Goodwin FLW, Campisi M, Babinska I, Amit Z (2001) Effects of naltrexone on the intake of ethanol and flavored solutions in rats. Alcohol 25:9-19.
20. Hyytia P (1993) Involvement of μ-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol Biochem Behav 45:697-701.
21. Hyytia P, Sinclair JD (1993) Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats. Alcohol Clin Exp Res 17:631-635.
22. Khalifa AE (2001) Hypericum perforatum as a nootropic drug: enhancement of retrieval memory of passive avoidance conditioning paradigm in mice. J Ethnopharmacol 76:49-57.
23. Klusa V, Germane S, Nöldner M, Chatterjee SS (2001) Hypericum extract and hyperforin: memory-enhancing properties in rodents. Pharmacopsychiatry (Suppl 1) 34:S61-S69.
24. Koch JE, Glass MJ, Cooper ML, Bodnar RJ (1995) Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats. Neuroscience 66:951-957.
25. Kosten TR, Kleber HD (1984) Strategies to improve compliance with narcotic antagonists. Am J Drug Alcohol Abuse 10:249-266.
26. Kumar V, Jaiswal AK, Singh PN, Bhattacharya SK (2000) Anxiolytic activity of Indian Hypericum Perforatum Linn: an experimental study. Indian J Exp Biol 38:36-41.
27. Kumar V, Singh PN, Bhattacharya SK (2001) Anti-inflammatory and analgesic activity of Indian Hypericum perforatum (Hp) L. Indian J Exp Biol 39:339-343.
28. Laakmann G, Schule C, Baghai T, Kieser M (1998) St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry (Suppl 1) 31:54-59.
29. 2A receptors in alcohol drinking: preference in HAD rats is inhibited by combination treatment with naltrexone and amperozide. Alcohol 13:53-57.
30. Le AD, Sellers EM (1994) Interaction between opiate and 5-HT3 receptor antagonists in the regulation of alcohol intake. Alcohol Alcohol (Suppl 2) 29:545-549.
31. Linde K, Mulrow CD (2000) St John's wort for depression. Cochrane Database Syst Rev 2:CD000448.
32. Lukas SE, Moreton JE (1979) A technique for chronic intragastric drug administration in the rat. Life Sci 25:593-600.
33. Lynch WC, Libby L (1983) Naloxone suppresses intake of highly preferred saccharin solutions in food deprived and sated rats. Life Sci 33:1909-1914.
34. Muller WE, Singer A, Wonnemann M (2001) Hyperforin - antidepressant activity by a novel mechanism of action. Pharmacopsychiatry (Suppl 1) 34:S98-S102.
35. Nathan PJ (1999) The experimental and clinical pharmacology of St. John's Wort (Hypericum perforatum L.). Mol Psychiatry 4:333-338.
36. Nevo I, Hamon M (1995) Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochem Int 26: 305-336.
37. O'Brien CP, Volpicelli LA, Volpicelli JR (1996) Naltrexone in the treatment of alcoholism: a clinical review. Alcohol 13:35-39.
38. O'Malley SS, Jaffe AJ, Chang G, Scottenfeld RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49:881-887.
39. Overstreet DH, Kampov-Polevoy AB, Rezvani AH, Braun C, Bartus RT, Crews FT (1999) Suppression of alcohol intake by chronic naloxone treatment in P rats: tolerance development and elevation of opiate receptor binding. Alcohol Clin Exp Res 23:1761-1771.
40. Panocka I, Perfumi M, Angeletti S, Ciccocioppo R, Massi M (2000) Effects of Hypericum perforatum extract on ethanol intake and on behavioral despair: a search for the neurochemical systems involved. Pharmacol Biochem Behav 66:105-111.
41. Parkes JH, Sinclair JD (2000) Reduction of alcohol drinking and upregulation of opioid receptors by oral naltrexone in AA rats. Alcohol 21: 215-221.
42. Pasternak GW (1993) Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16:1-18.
43. Perfumi M, Ciccocioppo R, Angeletti S, Cucculelli M, Massi M (1999) Effect of Hypericum perforatum extract on alcohol intake in Marchigian Sardinian alcohol-preferring rats. Alcohol Alcohol 34:690-698.
44. 2 extract of Hypericum perforatum on alcohol intake in rats. Alcohol Alcohol 36: 199-206.
45. Perfumi M, Santoni M, Ciccocioppo R, Massi M (2002) Blockade of GABA receptors does not modify the inhibition of ethanol intake induced by Hypericum perforatum in rats. Alcohol Alcohol 37:540-546.
46. Pulvirenti L, Kastin AJ (1988) Naloxone, but not Tyr-MIF-1, reduces volitional ethanol drinking in rats: correlation with degree of spontaneous preference. Pharmacol Biochem Behav 31:129-134.
47. Rabinowitz J, Cohen H, Alias S (2002) Outcomes of naltrexone maintenance following ultrarapid opiate detoxification versus intensive inpatient detoxification. Am J Addict 11:52-56.
48. Rabinowitz J, Cohen H, Tarrasch R, Kotler M (1997) Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study. Drug Alcohol Depend 47:77-86.
49. Rezvani AH, Overstreet DH, Mason GA, Janowsky DS, Hamedi M, Clark E, Yang Y (2000) Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduced alcohol intake in three strains of alcohol-preferring rats. Alcohol Alcohol 35:76-83.
50. Rezvani AH, Overstreet DH, Yang Y, Clark E Jr (1999) Attenuation of alcohol intake by the extract of Hypericum perforatum (St. John's Wort) in two different strains of alcohol-preferring rats. Alcohol Alcohol 34:699-705.
51. Salloum IM, Cornelius JR, Thase ME, Daley DC, Kirisci L, Spotts C (1998) Naltrexone utility in depressed alcoholics. Psychopharmacol Bull 34:111-115.
52. Sandi C, Borrell J, Guaza C (1988) Naloxone decreases ethanol consumption within a free choice paradigm in rats. Pharmacol Biochem Behav 29:39-43.
53. Sharpe AL, Samson HH (2001) Effect of naloxone on appetitive and consummatory phases of ethanol self-administration. Alcohol Clin Exp Res 25:1006-1011.
54. Simmen U, Burkard W, Berger K, Schaffner W, Lundstrom K (1999) Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system. J Recept Signal Transduct Res 19:59-74.
55. Simmen U, Schweitzer C, Burkard W, Shaffner W, Lundstrom K (1998) Hypericum perforatum inhibits the binding of μ- and κ-opioid receptor expressed with the Semliki Forest virus system. Pharm Acta Helv 73: 53-56.
56. +. J Pharmacol Exp Ther 290:1363-1368.
57. Stromberg MF, Mackler SA, Volpicelli JR, O'Brien C (2001) Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption. Alcohol 23:109-116.
58. Vandenbogaerde A, Zanoli P, Puia G, Truzzi C, Kamuhabwa A, De Witte P, Merlevede W, Baraldi M (2000) Evidence that total extract of Hypericum perforatum affects exploratory behavior and exerts anxiolytic effects in rats. Pharmacol Biochem Behav 65:627-633.
59. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880.
60. Volz HP (1997) Controlled clinical trials of hypericum extracts in depressed patients - an overview. Pharmacopsychiatry 30:72-76.
61. Vormfelde SV, Poser W (2000) Hyperforin in extracts of St. John's wort (Hypericum perforatum) for depression. Arch Intern Med 160:2548-2549.
62. Zink RW, Rohrbach K, Froehlich JC (1997) Naltrexone and fluoxetine act synergistically to decrease alcohol intake. Alcohol Clin Exp Res (Suppl) 21:105.